[Clinical practice guideline for quality control of hemodiafiltration]
Insights
This guideline provides expert recommendations for hemodiafiltration (HDF) in China, covering indications, treatment, and complication management to standardize medical quality.
Area of Science:
- Nephrology
- Renal Replacement Therapy
Context:
- Hemodiafiltration (HDF) is a crucial renal replacement therapy.
- Clinical practice guidelines and expert recommendations form the basis of this guideline.
- The Standard Operating Procedures for Blood Purification (2021 Edition) were also referenced.
Purpose:
- To guide clinical practice and research in hemodiafiltration within China.
- To enhance the standardization, normalization, and homogeneity of medical quality in HDF.
- To address key clinical and quality control issues in HDF.
Summary:
- Covers indications for hemodiafiltration, treatment mode selection, and replacement fluid adjustments.
- Addresses vascular access, anticoagulation therapy, prescription setting, and complication prevention/treatment.
- Based on evidence-based resources, current guidelines, and expert recommendations.
Impact:
- Aims to improve the quality of hemodiafiltration care in China.
- Promotes standardized and normalized medical practices.
- Facilitates advancements in clinical research for hemodiafiltration.
Abstract:
This guideline was co-authored by a writing committee of experts in hemodiafiltration. Based on the current evidence-based resources, the guideline drew on and referred to the current relevant clinical practice guidelines and expert recommendations at home and abroad, as well as the Standard Operating Procedures for Blood Purification (2021 Edition), focusing on clinical and medical quality control issues such as the indications for hemodiafiltration, the selection of treatment modes, the selection of replacement fluid and the adjustment of components, vascular access, anticoagulation therapy, prescription setting, and prevention and treatment of related complications. The guideline aimed to guide the clinical practice and clinical research of hemodiafiltration in China, and improve the standardization, normalization and homogeneity of medical quality of hemodiafiltration.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
10:19Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
Published on: February 13, 2016
Related Concept Videos
Dialysis
Pre-Procedural Guidelines for Assessing Blood Pressure
